Cited by 220Gastrointestinal motility and disordersGut microbiota and healthInflammatory Bowel Disease

The immune system in irritable bowel syndrome

Open access
Barbara, Giovanni, Cremon, Cesare, Carini, Giovanni, Bellacosa, Lara, Zecchi, Lisa, Giorgio, Roberto De, Corinaldesi, Roberto, Stanghellini, Vincenzo·2011·Journal of Neurogastroenterology and Motility

Abstract

The potential relevance of systemic and gastrointestinal immune activation in the pathophysiology and symptom generation in the irritable bowel syndrome (IBS) is supported by a number of observations. Infectious gastroenteritis is the strongest risk factor for the development of IBS and increased rates of IBS-like symptoms have been detected in patients with inflammatory bowel disease in remission or in celiac disease patients on a gluten free diet. The number of T cells and mast cells in the small and large intestine of patients with IBS is increased in a large proportion of patients with IBS over healthy controls. Mediators released by immune cells and likely from other non-immune competent cells impact on the function of enteric and sensory afferent nerves as well as on epithelial tight junctions controlling mucosal barrier of recipient animals, isolated human gut tissues or cell culture systems. Antibodies against microbiota antigens (bacterial flagellin), and increased levels of cytokines have been detected systemically in the peripheral blood advocating the existence of abnormal host-microbial interactions and systemic immune responses. Nonetheless, there is wide overlap of data obtained in healthy controls; in addition, the subsets of patients showing immune activation have yet to be clearly identified. Gender, age, geographic differences, genetic predisposition, diet and differences in the intestinal microbiota likely play a role and further research has to be done to clarify their relevance as potential mechanisms in the described immune system dysregulation. Immune activation has stimulated interest for the potential identification of biomarkers useful for clinical and research purposes and the development of novel therapeutic approaches.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5056/jnm.2011.17.4.349

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [56]Wang LH Fang XC Pan GZ Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis Gut 2004 53 1096 1101 15247174 PMC1774156

Cited by

Sorted by citations

Authors
Barbara, G., Cremon, C., Carini, G., Bellacosa, L., Zecchi, L., Giorgio, R. D., Corinaldesi, R., & Stanghellini, V.
Affiliations
University of Bologna (IT)
Corresponding author
Barbara, Giovanni
Venue
Journal of Neurogastroenterology and Motility
Published
2011-10-31
Volume
17
Issue
4
Pages
349-359
ISSN
  • 2093-0879 (ISSN-L)
  • 2093-0887
OpenAlex
W2154410960
Cited by
211
References
91
Citations by year
2026: 8 · 2025: 10 · 2024: 9 · 2023: 10 · 2022: 15 · 2021: 10 · 2020: 21 · 2019: 13 · 2018: 20 · 2017: 15 · 2016: 20 · 2015: 12 · 2014: 18 · 2013: 17 · 2012: 12
FWCI
15.76
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Journal of Neurogastroenterology and Motility (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
Keywords
irritable bowel syndrome, immune activation, gut microbiota, T cells, mast cells, enteric nerves, tight junctions, mucosal barrier, host-microbe interactions, inflammatory bowel disease, celiac disease, gluten-free diet, infectious gastroenteritis, cytokines, biomarkers, immune dysregulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review